Terms: = Bone cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Treatment
22 results:
1. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
[TBL] [Abstract] [Full Text] [Related]
2. Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia.
Gao XN; Su YF; Li MY; Jing Y; Wang J; Xu L; Zhang LL; Wang A; Wang YZ; Zheng X; Li YF; Liu DH
Cancer Immunol Immunother; 2023 Aug; 72(8):2769-2782. PubMed ID: 37166484
[TBL] [Abstract] [Full Text] [Related]
3. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
Dvorak CC; Haddad E; Heimall J; Dunn E; Cowan MJ; Pai SY; Kapoor N; Satter LF; Buckley RH; O'Reilly RJ; Chandra S; Bednarski JJ; Williams O; Rayes A; Moore TB; Ebens CL; Davila Saldana BJ; Petrovic A; Chellapandian D; Cuvelier GDE; Vander Lugt MT; Caywood EH; Chandrakasan S; Eissa H; Goldman FD; Shereck E; Aquino VM; Desantes KB; Madden LM; Miller HK; Yu L; Broglie L; Gillio A; Shah AJ; Knutsen AP; Andolina JP; Joshi AY; Szabolcs P; Kapadia M; Martinez CA; Parrot RE; Sullivan KE; Prockop SE; Abraham RS; Thakar MS; Leiding JW; Kohn DB; Pulsipher MA; Griffith LM; Notarangelo LD; Puck JM
J Allergy Clin Immunol; 2023 Feb; 151(2):547-555.e5. PubMed ID: 36456360
[TBL] [Abstract] [Full Text] [Related]
4. IL-7: Comprehensive review.
Winer H; Rodrigues GOL; Hixon JA; Aiello FB; Hsu TC; Wachter BT; Li W; Durum SK
Cytokine; 2022 Dec; 160():156049. PubMed ID: 36201890
[TBL] [Abstract] [Full Text] [Related]
5. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract] [Full Text] [Related]
6. The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study.
Ronsley R; Kariminia A; Ng B; Mostafavi S; Reid G; Subrt P; Hijiya N; Schultz KR
Pediatr Hematol Oncol; 2019 Nov; 36(8):468-481. PubMed ID: 31530240
[No Abstract] [Full Text] [Related]
7. Stereotactic Ablative Radiation Therapy for Pulmonary Recurrence-Based Oligometastatic Non-Small Cell Lung cancer: Survival and Prognostic Value of Regulatory T Cells.
Liu C; Sun B; Hu X; Zhang Y; Wang Q; Yue J; Yu J
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1055-1064. PubMed ID: 31437470
[TBL] [Abstract] [Full Text] [Related]
8. Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer.
Ke B; Wu X; Yang Q; Huang Y; Wang F; Gong Y; Liu J; Shi L
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138762
[TBL] [Abstract] [Full Text] [Related]
9. High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.
Adams HC; Stevenaert F; Krejcik J; Van der Borght K; Smets T; Bald J; Abraham Y; Ceulemans H; Chiu C; Vanhoof G; Usmani SZ; Plesner T; Lonial S; Nijhof I; Lokhorst HM; Mutis T; van de Donk NWCJ; Sasser AK; Casneuf T
Cytometry A; 2019 Mar; 95(3):279-289. PubMed ID: 30536810
[TBL] [Abstract] [Full Text] [Related]
10. Co-existence of il7r high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction.
Ge Z; Gu Y; Xiao L; Han Q; Li J; Chen B; Yu J; Kawasawa YI; Payne KJ; Dovat S; Song C
Oncotarget; 2016 Jul; 7(29):46014-46027. PubMed ID: 27322554
[TBL] [Abstract] [Full Text] [Related]
11. Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment.
Kordasti S; Costantini B; Seidl T; Perez Abellan P; Martinez Llordella M; McLornan D; Diggins KE; Kulasekararaj A; Benfatto C; Feng X; Smith A; Mian SA; Melchiotti R; de Rinaldis E; Ellis R; Petrov N; Povoleri GA; Chung SS; Thomas NS; Farzaneh F; Irish JM; Heck S; Young NS; Marsh JC; Mufti GJ
Blood; 2016 Sep; 128(9):1193-205. PubMed ID: 27281795
[TBL] [Abstract] [Full Text] [Related]
12. Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.
Rozovski U; Li P; Harris D; Ohanian M; Kantarjian H; Estrov Z
Cancer Med; 2014 Jun; 3(3):550-4. PubMed ID: 24678068
[TBL] [Abstract] [Full Text] [Related]
13. Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial.
Guttilla A; Bortolus R; Giannarini G; Ghadjar P; Zattoni F; Gnech M; Palumbo V; Valent F; Garbeglio A; Zattoni F
Radiat Oncol; 2014 Jan; 9():24. PubMed ID: 24423462
[TBL] [Abstract] [Full Text] [Related]
14. Polymorphism in the interleukin-7 receptor-alpha and outcome after allogeneic hematopoietic cell transplantation with matched unrelated donor.
Shamim Z; Spellman S; Haagenson M; Wang T; Lee SJ; Ryder LP; Müller K
Scand J Immunol; 2013 Aug; 78(2):214-20. PubMed ID: 23692589
[TBL] [Abstract] [Full Text] [Related]
15. Expression of CD30 in patients with acute graft-versus-host disease.
Chen YB; McDonough S; Hasserjian R; Chen H; Coughlin E; Illiano C; Park IS; Jagasia M; Spitzer TR; Cutler CS; Soiffer RJ; Ritz J
Blood; 2012 Jul; 120(3):691-6. PubMed ID: 22661699
[TBL] [Abstract] [Full Text] [Related]
16. LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-β and BMP-associated proinflammatory and proangiogenic signals.
Flechsig P; Dadrich M; Bickelhaupt S; Jenne J; Hauser K; Timke C; Peschke P; Hahn EW; Gröne HJ; Yingling J; Lahn M; Wirkner U; Huber PE
Clin Cancer Res; 2012 Jul; 18(13):3616-27. PubMed ID: 22547771
[TBL] [Abstract] [Full Text] [Related]
17. Development of an instrument to measure adherence to strength training in postmenopausal breast cancer survivors.
Huberty JL; Vener J; Waltman N; Ott C; Twiss J; Gross G; McGuire R; Dwyer A
Oncol Nurs Forum; 2009 Sep; 36(5):E266-73. PubMed ID: 19726386
[TBL] [Abstract] [Full Text] [Related]
18. Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients.
Derhovanessian E; Adams V; Hähnel K; Groeger A; Pandha H; Ward S; Pawelec G
Int J Cancer; 2009 Sep; 125(6):1372-9. PubMed ID: 19533748
[TBL] [Abstract] [Full Text] [Related]
19. Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.
Stinchcombe TE; Socinski MA; Lee CB; Hayes DN; Moore DT; Goldberg RM; Dees EC
J Thorac Oncol; 2008 May; 3(5):521-6. PubMed ID: 18449006
[TBL] [Abstract] [Full Text] [Related]
20. Allogeneic haematopoietic cell transplantation for multiple myeloma: reducing transplant-related mortality while harnessing the graft-versus-myeloma effect.
Zeiser R; Finke J
Eur J Cancer; 2006 Jul; 42(11):1601-11. PubMed ID: 16759847
[TBL] [Abstract] [Full Text] [Related]
[Next]
